Innova Captab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DUT01020
  • NSEID: INNOVACAP
  • BSEID: 544067
INR
688.45
-8.85 (-1.27%)
BSENSE

Dec 19

BSE+NSE Vol: 25.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039112,
    "name": "Innova Captab",
    "stock_name": "Innova Captab",
    "full_name": "Innova Captab Ltd",
    "name_url": "stocks-analysis/innova-captab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "688.45",
    "chg": -8.85,
    "chgp": "-1.27%",
    "dir": -1,
    "prev_price": "697.30",
    "mcapval": "3,960.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544067",
    "symbol": "INNOVACAP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DUT01020",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "25.05 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innova-captab-10039112-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Innova Captab’s Evaluation Revised Amidst Challenging Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-downgraded-to-strong-sell-amid-weak-financial-and-technical-indicators-3763656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_mojoScore_3763656.png",
        "date": "2025-12-19 10:10:48",
        "description": "Innova Captab has undergone a revision in its market assessment reflecting shifts in its financial health and technical outlook. The recent changes highlight concerns over the company’s operational cash flows, profitability metrics, and stock price momentum, set against a backdrop of subdued sector performance and a contracting market capitalisation."
      },
      {
        "title": "Innova Captab Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-opens-with-significant-gap-down-amid-market-concerns-3754951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_gapdown_3754951.png",
        "date": "2025-12-10 09:36:51",
        "description": "Innova Captab witnessed a sharp gap down at the opening bell, reflecting heightened market apprehension following overnight developments. The stock opened lower by 5.39%, underperforming its sector and broader market indices, signalling a cautious start to the trading day."
      },
      {
        "title": "Innova Captab Hits Intraday High Amid Strong Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-hits-intraday-high-with-1038-surge-on-9-dec-2025-3754025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_priceRelatedfactors_3754025.png",
        "date": "2025-12-09 15:37:21",
        "description": "Innova Captab recorded a robust intraday performance on 9 December 2025, surging to an intraday high of Rs 774.4, reflecting a 15.95% rise from its previous close. This marked a notable turnaround following three consecutive sessions of decline, with the stock outperforming its Pharmaceuticals & Biotechnology sector peers by 10.5% during the trading day."
      },
      {
        "title": "Innova Captab Falls to 52-Week Low of Rs.655.15 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-stock-falls-to-52-week-low-of-rs65515-amidst-weak-performance-3753708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_priceRelatedfactors_3753708.png",
        "date": "2025-12-09 10:54:00",
        "description": "Innova Captab has reached a new 52-week low of Rs.655.15, marking a significant price level for the pharmaceutical and biotechnology company. This decline comes amid broader market fluctuations and sector-specific pressures, with the stock trading below all major moving averages."
      },
      {
        "title": "Innova Captab Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-faces-intensified-downtrend-amid-technical-momentum-shift-3752970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_technicaldot_3752970.png",
        "date": "2025-12-09 08:20:44",
        "description": "Innova Captab’s stock price has experienced a notable shift in momentum, reflecting a series of technical indicator signals that suggest a bearish trend in the near term. The pharmaceutical and biotechnology company’s recent price movements and technical parameters reveal a complex market assessment, with mixed signals from key indicators such as MACD, RSI, and moving averages."
      },
      {
        "title": "Innova Captab Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-technical-momentum-shifts-amid-prolonged-downtrend-3740475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_technicaldot_3740475.png",
        "date": "2025-12-02 08:13:25",
        "description": "Innova Captab, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from bearish to mildly bearish trends. Despite a subdued price movement, the stock’s technical indicators present a complex picture that investors and analysts are closely monitoring amid broader market dynamics."
      },
      {
        "title": "How has been the historical performance of Innova Captab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-innova-captab-3739421",
        "imagepath": "",
        "date": "2025-12-01 23:42:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the fiscal years ending March 2023 to March 2025, Innova Captab’s net sales have shown a steady increase, rising from ₹926.38 crores in March 2023 to ₹1,243.68 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and sales capabilities. Correspondingly, the total operating income mirrored this growth, with no other operating income reported during this period.</p>\n<p>The company’s operating profit before depreciation, interest, and tax (PBDIT) also improved significantly, climbing from ₹122.85 crores in March 2023 to ₹198.21 crores in March 2025. This increase was supported by a rising operating profit margin, which expanded from 12.27% to 14.97%, indicating enhanced operational efficie..."
      },
      {
        "title": "Innova Captab's Evaluation Metrics Revised Amidst Challenging Market Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3735242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnovaCaptab_mojoScore_3735242.png",
        "date": "2025-11-28 10:05:12",
        "description": "Innova Captab has experienced a revision in its evaluation metrics reflecting recent financial and technical developments. The pharmaceutical and biotechnology small-cap company’s assessment now signals a more cautious market outlook, influenced by its operational results and stock performance trends."
      },
      {
        "title": "Innova Captab Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-hits-intraday-high-with-849-surge-on-25-nov-2025-3728142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnovaCaptab_priceRelatedfactors_3728142.png",
        "date": "2025-11-25 09:43:01",
        "description": "Innova Captab recorded a notable surge today, touching an intraday high of Rs 791.25, reflecting a gain of 8.49% amid heightened volatility and active trading. This performance stands out despite the stock’s recent downward trend over the past two sessions."
      }
    ],
    "total": 473,
    "sid": "10039112",
    "stock_news_url": "https://www.marketsmojo.com/news/innova-captab-10039112"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Dec-2025",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the official(s)/ representative(s) of the Company will be meeting and interacting with the Investors/Analysts (Participants) on 16th December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to the Regulation 30 read with Schedule III Part A - Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be attending the Investor Conference scheduled to be held on Friday 21 November 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "13-Nov-2025",
      "details": "Transcript of the Investor/Analyst Earnings Call held on 10th November 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

How has been the historical performance of Innova Captab?

2025-12-01 23:42:18

Revenue and Profit Growth

Over the fiscal years ending March 2023 to March 2025, Innova Captab’s net sales have shown a steady increase, rising from ₹926.38 crores in March 2023 to ₹1,243.68 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and sales capabilities. Correspondingly, the total operating income mirrored this growth, with no other operating income reported during this period.

The company’s operating profit before depreciation, interest, and tax (PBDIT) also improved significantly, climbing from ₹122.85 crores in March 2023 to ₹198.21 crores in March 2025. This increase was supported by a rising operating profit margin, which expanded from 12.27% to 14.97%, indicating enhanced operational efficie...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

10-Dec-2025 | Source : BSE

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the official(s)/ representative(s) of the Company will be meeting and interacting with the Investors/Analysts (Participants) on 16th December 2025

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

15-Nov-2025 | Source : BSE

Pursuant to the Regulation 30 read with Schedule III Part A - Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be attending the Investor Conference scheduled to be held on Friday 21 November 2025.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

13-Nov-2025 | Source : BSE

Transcript of the Investor/Analyst Earnings Call held on 10th November 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available